FDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL Treatment
August 01, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
La FDA accorde le statut de médicament orphelin à CLLS52 (alemtuzumab) de Cellectis pour le traitement de la LLA
August 01, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, 01 août 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) (la « Société »), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière...
The Pennant Group Announces New $250 Million Credit Facility
August 01, 2024 16:21 ET
|
Pennant Group, Inc.
EAGLE, Idaho, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today...
CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors
August 01, 2024 16:15 ET
|
Centogene NV
Initial data from largest international Parkinson’s disease patient cohort shows approximately 90% of these genetically confirmed patients had variants in the LRRK2 or GBA1 genes, making these...
Clarus Reports Second Quarter 2024 Results
August 01, 2024 16:15 ET
|
Clarus Corporation
Makes Incremental Progress Executing Strategic Initiatives to Accelerate Long-Term Growth Three Veteran Operating and Sales Executives Added to Adventure Team to Support U.S., International and OEM...
Regency Centers Reports Second Quarter 2024 Results
August 01, 2024 16:15 ET
|
Regency Centers Corporation
JACKSONVILLE, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers”, “Regency” or the “Company”) (Nasdaq: REG) today reported financial and operating results for the...
DraftKings Reports Second Quarter Revenue Growth of 26% to $1,104 Million; Announces $1.0 Billion Inaugural Share Repurchase Authorization
August 01, 2024 16:15 ET
|
DK Crown Holdings Inc.
BOSTON, Aug. 01, 2024 (GLOBE NEWSWIRE) -- DraftKings Inc. (Nasdaq: DKNG) (“DraftKings” or the “Company”) today announced results for the second quarter of 2024 and that its Board of Directors...
BetMGM and Inspired Entertainment Bring MGM Bonus City to Michigan
August 01, 2024 16:15 ET
|
Inspired Entertainment, Inc.
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. (NASDAQ: INSE), a leading provider of B2B gaming content, technology, hardware, and services, and BetMGM, a leading iGaming...
Appian To Participate in Upcoming Investor Conferences
August 01, 2024 16:15 ET
|
Appian Corporation
MCLEAN, Va., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) announced today that management will be presenting and hosting meetings with institutional investors at the following upcoming...
Trupanion to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 01, 2024 16:15 ET
|
Trupanion, Inc.
SEATTLE, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) announced today that Margi Tooth, President and Chief Executive Officer, and Fawwad Qureshi, Chief Financial Officer, will...